Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Open Payments and the US Clinical Landscape.

Therapeutic innovation & regulatory science·2020
Same author

Pharmaceutical Organizational Size and Phase 3 Clinical Trial Completion Times.

Therapeutic innovation & regulatory science·2018
Same author

Are Phase 3 Clinical Trials Really Becoming More Complex?

Therapeutic innovation & regulatory science·2018
Same author

ClinicalTrials.gov: An Underutilized Source of Research Data About the Design and Conduct of Commercial Clinical Trials.

Therapeutic innovation & regulatory science·2018
Same author

The profile of the one-time 1572 investigator.

Contemporary clinical trials·2008
Same author

Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?

Disease management : DM·2004

Related Experiment Video

Updated: Jun 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Managing clinical grant costs.

Harold E Glass1, Karen Hollander

  • 1University of the Sciences in Philadelphia, Philadelphia, PA 19104, USA. h.glass@usp.edu

Contemporary Clinical Trials
|May 28, 2009
PubMed
Summary
This summary is machine-generated.

Managing clinical grant costs is crucial for pharmaceutical R&D. Effective financial management ensures value and supports bringing new drugs to patients efficiently.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Jun 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

  • Pharmaceutical Research & Development
  • Clinical Trial Management
  • Healthcare Economics

Background:

  • Rising pharmaceutical R&D costs pose significant industry challenges.
  • Clinical grants represent a key area of expenditure within R&D.
  • Physician compensation is a critical factor in clinical trial participation.

Purpose of the Study:

  • To examine the role of clinical grant payments in motivating trial participation.
  • To outline effective management practices for controlling clinical grant costs.
  • To provide guidance for optimizing clinical grant expenditures in pharmaceutical R&D.

Main Methods:

  • Analysis of the relationship between financial compensation and investigator motivation.
  • Review of current industry practices for managing clinical grant budgets.
  • Exploration of the financial dynamics between pharmaceutical sponsors and clinical investigators.

Main Results:

  • Financial compensation is important for many physicians, particularly in office-based and Phase 4 trials.
  • High grant rates do not consistently guarantee timely performance or data quality.
  • Effective management requires understanding the sponsor-investigator relationship and maximizing value.

Conclusions:

  • Pharmaceutical companies must manage clinical grant funds judiciously.
  • Sound financial management balances business sense with the goal of developing new medicines.
  • Well-managed clinical grants benefit society, industry, investigators, and patients.